Florida Resident Sues Prinston Pharmaceutical for Presence of Carcinogens in Over-the-Counter Blood Pressure Medication
On October 25, 2018, Florida resident Ron Molinaro filed a complaint against Prinston Pharmaceutical Inc., Solco Healthcare LLC, Solco Healthcare U.S. LLC, and Huahai US Inc. in the U.S. District Court of the Middle District of Florida. Molinaro alleged that the generic blood pressure medication he bought (Valsartan-Hydrochlorothiazide) contained a potentially carcinogenic substance (N-nitrosodimethylamine) due to mistakes made during the drug manufacturing process. By filing a product liability lawsuit against the aforementioned parties, Molinaro aims to recover damages, punitive damages, restitution, and/or injunctive relief for the harmful conduct of the pharmaceutical manufacturers involved.
According to the plaintiff, the Valsartan medications created by the named pharmaceutical companies failed to conform to their warranties and representations of the product due to the fact that it was not created in a manner compliant with current manufacturing regulations. Molinaro also alleges that, as a result, the Valsartan products he used were adulterated.
Valsartan Lawyers Serving Clients Nationwide
At Golomb Legal, P.C., we serve clients throughout the United States who have been negatively affected by the unsafe, harmful practices of pharmaceutical manufacturers. We are currently representing Mr. Molinaro, and we are pleased to play a central role in holding pharmaceutical companies responsible for their negligence, especially when it causes harm to consumers.
If you have been harmed due to a dangerous medication, we may be able to review your case and help you evaluate your options. Evidence of a pharmaceutical manufacturer’s liability in your case could allow you to recover compensation for related expenses, such as medical care, lost wages, etc. Connect with a member of our team today to speak to a national dangerous drug attorney.
Call (215) 278-4449 today to schedule your free, no-obligation consultation.